CLSI EP12-A2
September 11, 2020
No Comments
This document contains a protocol that optimizes the experimental design for the evaluation of qualitative tests, to better measure performance and provide a structured data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
Product Details
- Edition:
- 2nd
- Published:
- 01/01/2008
- ISBN(s):
- 1562386549
- Number of Pages:
- 64
- File Size:
- 1 file , 1.5 MB